BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 3, 2017
View Archived Issues
Regen Biopharma enters agreement to optimize NR2F6 modulators
Read More
Hope Biosciences gains rights to MERTK/AXL inhibitor from NeoPharm
Read More
Biogen completes separation of global hemophilia business and launches Bioverativ
Read More
FDA orphan drug status given to CyTIX-DCf 12-GLI for malignant glioma
Read More
Increased potency of CB-2679d may allow subcutaneous dosing for hemophilia B
Read More
FDA grants accelerated approval to Opdivo in metastatic urothelial carcinoma
Read More
FDA grants authorization for Abbott RealTime ZIKA test to detect Zika virus using whole blood
Read More
Vividion Therapeutics launches with novel drug discovery platform
Read More
Protagen and NCI collaborate to provide insight into immuno-oncology
Read More
Repatha cardiovascular outcomes study and cognition function study meet primary endpoints
Read More
Summit Therapeutics outlines phase III program for ridinilazole
Read More
Fortress Biotech's Mustang Bio closes private placement financing to support immunotherapy pipeline
Read More
Sustained factor IX activity seen with single infusion of SPK-9001 gene therapy
Read More
Galapagos begins dosing patients with cystic fibrosis in ALBATROSS study
Read More
GenomeDx to perform genomic tumor profiling for Astellas' ENACT study of enzalutamide
Read More
Aviragen reports topline data from phase IIa study of BTA-585 for RSV
Read More
Soligenix's SGX-301 granted PIM designation in U.K.
Read More
FDA gives orphan drug designation to Lysogene's gene therapy candidate for GM1 gangliosidosis
Read More
Glecaprevir/pibrentasvir NDA granted priority review by FDA
Read More
Guangzhou Maxinovel Pharmaceuticals divulges novel tyrosine kinase inhibitors
Read More
Sunshine Lake Pharma patents orexin receptor antagonists
Read More
Bayer discloses new mutant IDH1 inhibitors
Read More
Ono Pharmaceutical discovers prostanoid EP2 receptor agonists
Read More
Astellas Pharma offers overview of third quarter of fiscal 2016
Read More
Pharmakea presents novel lysyl oxidase homolog 2 inhibitors
Read More
Daiichi Sankyo reports key milestones of third quarter of fiscal 2016
Read More
Promising MOD-5014 results in a phase I/IIa clinical trial in hemophilia patients
Read More